Pfizer will continue to soar short term. There are so little competition for vaccines.
How Much Revenue Could Pfizer's Oral COVID-19 Pill Fetch?
Pfizer, Inc. announced Wednesday its oral COVID-19 antiviral pill, Paxlovid, has been authorized for
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
1
举报
登录后可参与评论
暂无评论